Tremfya (guselkumab) is a biologic medication approved by the FDA to treat moderate to severe plaque psoriasis. It works by targeting a specific part of the immune system to reduce inflammation and help clear skin. Some encouraging findings about Tremfya include:
- Nearly 3 out of 4 participants in one study achieved clear Show Full Answer
Tremfya (guselkumab) is a biologic medication approved by the FDA to treat moderate to severe plaque psoriasis. It works by targeting a specific part of the immune system to reduce inflammation and help clear skin. Some encouraging findings about Tremfya include:
- Nearly 3 out of 4 participants in one study achieved clear or almost clear skin
- Results were seen across all skin tones
- About 60% of participants with psoriatic arthritis also saw meaningful improvement in joint symptoms after 16 weeks
- It's given as an injection, typically on a schedule that's less frequent than daily treatments Like all biologics, Tremfya works by dampening part of the immune system, which does come with an increased risk of infection. It's really important to weigh the benefits and risks with a dermatologist before starting.
Everyone responds differently to medications, so what works well for one person may not be the best fit for another. A doctor can help figure out if Tremfya is the right option based on individual health history and needs.
June 18
Join
Your Privacy Choices
